Skip to main content
SpringerLink
Log in
Book cover

Annual Update in Intensive Care and Emergency Medicine 2012 pp 253–263Cite as

Severe Community-acquired Pneumonia

  • Chapter

  • 2262 Accesses

Part of the book series: Annual Update in Intensive Care and Emergency Medicine ((AUICEM,volume 2012))

Abstract

Severe community-acquired pneumonia (CAP) is an important disease and on many intensive care units (ICUs) it is one of the most prevalent infectious diseases. Despite advances in antimicrobial therapy, rates of mortality from CAP remain unacceptably high. In fact, mortality rates have not decreased significantly since penicillin became routinely available and CAP remains the seventh leading cause of death in the United States [1, 2]. Estimates of the incidence of CAP range from 4 million to 5 million cases per year in the United States, with about 500,000 patients requiring hospitalization and 45,000 deaths annually [3].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Feikin DR, Schuchat A, Kolczak M, et al (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health 90: 223–229

    Article  PubMed  CAS  Google Scholar 

  2. Hoyert DL, Heron MP, Murphy SL, et al (2006) Deaths: final data for 2003. Natl Vital Stat Rep 54: 1–120

    PubMed  Google Scholar 

  3. Brown SM, Dean NC (2010) Defining and predicting severe community-acquired pneumonia. Curr Opin Infect Dis 23: 158–164

    Article  PubMed  Google Scholar 

  4. Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of communityacquired pneumonia among adults in Europe. Thorax 67: 71–79

    Article  PubMed  CAS  Google Scholar 

  5. Bauer TT, Welte T, Ernen C, et al (2005) Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 128: 2238–2246

    Article  PubMed  Google Scholar 

  6. Angus DC, Marrie TJ, Obrosky DS, et al (2002) Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med 166: 717–723

    Article  PubMed  Google Scholar 

  7. El Moussaoui R, Opmeer BC, de Borgie CA, et al (2006) Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe communityacquired pneumonia. Chest 130: 1165–1172

    Article  PubMed  Google Scholar 

  8. Rodríguez A, Mendia A, Sirvent JM, et al (2007) Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 35: 1493–1498

    Article  PubMed  Google Scholar 

  9. Woodhead M, Welch CA, Harrison DA, et al (2006) Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Crit Care 10 (Suppl 2): S 1

    Article  Google Scholar 

  10. Ewig S (2011) Gains and limitations of predictive rules for severe community-acquired pneumonia. Clin Infect Dis 53: 512–514

    Article  PubMed  Google Scholar 

  11. Renaud B, Santin A, Coma E, et al (2009) Association between timing of intensive care unit admission and outcomes for emergency department patients with community acquired pneumonia. Crit Care Med 37: 2867–2874

    Article  PubMed  Google Scholar 

  12. Restrepo MI, Mortensen EM, Rello J, et al (2010) Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 137: 552–557.

    Article  PubMed  Google Scholar 

  13. Marrie TJ, Shariatzadeh MR (2007) Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 86: 103–111

    Article  Google Scholar 

  14. Chalmers JD, Taylor JK, Mandal P, et al (2011) Validation of the Infectious Diseases Society Of America/American Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 53: 503–511

    Article  PubMed  Google Scholar 

  15. Charles PG, Wolfe R, Whitby M, et al (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47: 375–384

    Article  PubMed  Google Scholar 

  16. Ewig S, Woodhead M, Torres A (2011) Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med 37: 214–223

    Article  PubMed  Google Scholar 

  17. Mulrennan S, Tempone SS, Ling IT, et al (2010) Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable. PLoS One 5: e12849

    Article  PubMed  Google Scholar 

  18. Bloos F, Marshall JC, Dellinger RP, et al (2011) Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 15: R88

    Article  PubMed  Google Scholar 

  19. Barlow G, Nathwani D, Davey P (2007) The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community acquired pneumonia. Thorax 62: 253–259

    Article  PubMed  Google Scholar 

  20. Mandell LA, Wunderink RG, Anzueto A, et al (2007) Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults. Clin Infect Dis 44 (Suppl 2): S27–S72

    Article  PubMed  CAS  Google Scholar 

  21. Woodhead M, Blasi F, Ewig S, et al (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26: 1138–1180

    Article  PubMed  CAS  Google Scholar 

  22. Martin-Loeches I, Lisboa T, Rodriguez A, et al (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36: 612–620

    Article  PubMed  CAS  Google Scholar 

  23. Martínez R, Reyes S, Lorenzo MJ, et al (2009) Impact of guidelines on outcome: the evidence. Semin Respir Crit Care Med 30: 172–178

    Article  PubMed  Google Scholar 

  24. Menéndez R, Torres A, Reyes S, et al (2012) Initial management of pneumonia and sepsis. Factors associated with improved outcome. Eur Respir J 39: 156–162

    Article  PubMed  Google Scholar 

  25. Vardakas KZ, Siempos II, Grammatikos A, et al (2008) Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ 179: 1269–1277

    PubMed  Google Scholar 

  26. Dellinger RP, Levy MM, Carlet JM, et al (2008) Surviving Sepsis Campaign: international guidelines formanagement of severe sepsis and septic shock: 2008. Crit Care Med 36: 296–327

    Article  PubMed  Google Scholar 

  27. Kumar A, Ellis P, Arabi Y, et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136: 1237–1248

    Article  PubMed  Google Scholar 

  28. Bruns AH, Oosterheert JJ, Hustinx WN, et al (2009) Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 28: 913–919

    Article  PubMed  CAS  Google Scholar 

  29. Pines JM, Isserman JA, Hinfey PB (2009) The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 37: 335–340

    Article  PubMed  Google Scholar 

  30. Aliberti S, Blasi F, Zanaboni AM, et al (2010) Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J 36: 128–134

    Article  PubMed  CAS  Google Scholar 

  31. Schuetz P, Christ-Crain M, Thomann R, et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302: 1059–1066

    Article  PubMed  CAS  Google Scholar 

  32. Bouadma L, Luyt CE, Tubach F, et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375: 463–474

    Article  PubMed  CAS  Google Scholar 

  33. Ambrose PG (2008) Use of pharmacokinetics and pharmacodynamics in a failure analysis of community-acquired pneumonia: implications for future clinical trial study design. Clin Infect Dis 47 (Suppl 3): S225–S231

    Article  PubMed  CAS  Google Scholar 

  34. Blot SI, Rodriguez A, Solé-Violán J, et al (2007) Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 35: 2509–2514

    Article  PubMed  Google Scholar 

  35. Carron M, Freo U, Zorzi M, et al (2010) Predictors of failure of noninvasive ventilation in patients with severe community-acquired pneumonia. J Crit Care 25: 540.e9–14

    Article  Google Scholar 

  36. Gattinoni L, Carlesso E, Taccone P, et al (2010) Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis. Minerva Anestesiol 76: 448–454

    PubMed  CAS  Google Scholar 

  37. Chan MC, Hsu JY, Liu HH, et al (2007) Effects of prone position on inflammatory markers in patients with ARDS due to community-acquired pneumonia. J Formos Med Assoc 106: 708–716

    Article  PubMed  CAS  Google Scholar 

  38. Guerin C, Gaillard S, Lemasson S, et al (2004) Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 292: 2379–2387

    Article  PubMed  CAS  Google Scholar 

  39. Thomas PJ, Paratz JD (2007) Is there evidence to support the use of lateral positioning in intensive care? A systematic review. Anaesth Intensive Care 35: 239–255

    PubMed  CAS  Google Scholar 

  40. Marquette CH, Wermert D, Wallet F, et al (1997) [Fibroscopic bronchoscopy in intensive care]. Rev Mal Respir 14: 101–111

    PubMed  CAS  Google Scholar 

  41. Fartoukh M, Azoulay E, Galliot R, et al (2002) Clinically documented pleural effusions in medical ICU patients: how useful is routine thoracentesis? Chest 121: 178–184

    Article  PubMed  Google Scholar 

  42. Tu CY, Hsu WH, Hsia TC, et al (2006) The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit. Intensive Care Med 32: 570–576

    Article  PubMed  Google Scholar 

  43. The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators (2009) Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 302: 1888–1895

    Article  Google Scholar 

  44. Meduri GU, Rocco PR, Annane D, et al (2010) Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome. Expert Rev Respir Med 4: 201–210

    Article  PubMed  CAS  Google Scholar 

  45. Snijders D, Daniels JM, de Graaff CS, et al (2010) Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 181: 975–982

    Article  PubMed  CAS  Google Scholar 

  46. Meijvis SC, Hardeman H, Remmelts HH, et al (2011) Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 377: 2023–2030

    Article  PubMed  CAS  Google Scholar 

  47. Black PN, Morgan-Day A, McMillan TE, et al (2004) Randomised, controlled trial of Nacetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med 4: 13

    Article  PubMed  Google Scholar 

  48. Chalmers JD, Singanayagam A, Murray MP, et al (2008) Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 121: 1002–1007

    Article  PubMed  CAS  Google Scholar 

  49. Yende S, Milbrandt EB, Kellum JA, et al (2011) Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 39: 1871–1878

    Article  PubMed  CAS  Google Scholar 

  50. Pham JC, Kelen GD, Pronovost PJ (2007) National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia. Acad Emerg Med 14: 856–863

    Article  PubMed  Google Scholar 

  51. Laterre PF, Garber G, Levy H, et al (2005) Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med 33: 952–961

    Article  PubMed  Google Scholar 

Download references

Authors
  1. J. Vergragt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Kesecioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. W. de Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vergragt, J., Kesecioglu, J., de Lange, D.W. (2012). Severe Community-acquired Pneumonia. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2012. Annual Update in Intensive Care and Emergency Medicine, vol 2012. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25716-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-25716-2_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25715-5

  • Online ISBN: 978-3-642-25716-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation